Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Germflare Aps maintains 1 pending office action within the Chemistry & Materials technology area. The portfolio's current activity is limited to 1 distinct examiner and a single distinct art unit, reflecting a narrow scope of active prosecution. This concentration indicates that the company is currently pursuing a specific technological path rather than a broad array of chemical innovations.
The busiest examiner, CLEVELAND, TIMOTHY C, is responsible for the pending office action. This centralization means that the company's immediate patenting success in this technology area relies on navigating the requirements of this specific examiner. Strategy should be tailored to this individual's historical approach to chemistry-related claims, as there are no other examiners currently reviewing the company's work to provide a different perspective.
With only a single distinct art unit involved, the company faces a streamlined but high-stakes examination process. There is no internal comparison available within the portfolio to gauge how different units might treat the company's technology. Consequently, the interaction with the current examiner and art unit will be the sole determinant of the company's progress in the current patent cycle. The resolution of this office action is critical for the company's standing in the Chemistry & Materials field.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CLEVELAND, TIMOTHY C | 1 | 59.9% | +18.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18019820 | DECONTAMINATION DEVICE, DECONTAMINATION ASSEMBLY, DECONTAMINATION SYSTEM, AND RELATED METHODS | CLEVELAND, TIMOTHY C | 15d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18019820 | DECONTAMINATION DEVICE, DECONTAMINATION ASSEMBLY, DECONTAMINATION SYSTEM, AND RELATED METHODS | CLEVELAND, TIMOTHY C | 15d overdue |
| Art Unit | Apps |
|---|---|
| 1774 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18019820 | DECONTAMINATION DEVICE, DECONTAMINATION ASSEMBLY, DECONTAMINATION SYSTEM, AND RELATED METHODS | CLEVELAND, TIMOTHY C | 1774 | §103§112 | Final Rejection | 15d overdue | Pending | Feb 05, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGermflare Aps has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Timothy C Cleveland has the most, with 1 of Germflare Aps's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.